These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7296672)

  • 1. Surface analysis of early and late MOPC-3 15-EL tumor cells.
    Harris D; Bailey J; Lewis JC; Grover WH; Panetti M; Evans DL; Ruebush MJ; Paulus LK; Burgess D; Hale AH
    Cell Immunol; 1981 Oct; 64(1):119-30. PubMed ID: 7296672
    [No Abstract]   [Full Text] [Related]  

  • 2. F1 hybrid resistance to murine plasmacytoma MOPC-70A: hybrid resistance to MOPC-70A controlled by a locus linked to H-2.
    Kaneko Y; Natsuume-Sakai S; Moriwaki K; Migita S
    J Immunol; 1980 Nov; 125(5):2031-8. PubMed ID: 7430619
    [No Abstract]   [Full Text] [Related]  

  • 3. Relationship of expression of A cell-surface antigen on activated murine macrophages to tumor cell cytotoxicity.
    Kaplan AM; Bear HD; Kirk L; Cummins C; Mohanakumar T
    J Immunol; 1978 Jun; 120(6):2080-5. PubMed ID: 659893
    [No Abstract]   [Full Text] [Related]  

  • 4. A new T cell neoplasm expressing surface anti-DNP activity, developed from the thymus of mice bearing MOPC-315 plasma cell tumors.
    Lahat N; Moroz C
    Adv Exp Med Biol; 1976; 66():477-81. PubMed ID: 1083649
    [No Abstract]   [Full Text] [Related]  

  • 5. H-2-restricted T-cell-mediated cytotoxicity: rediscovering allo-H-2-reactivity?
    Dennert G
    Cell Immunol; 1980 Jan; 49(1):12-25. PubMed ID: 6965359
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of the YC8 lymphoma growth by alloimmunization with normal cells.
    Parmiani G; Sensi ML
    Transplant Proc; 1981 Dec; 13(4):1906-9. PubMed ID: 7330975
    [No Abstract]   [Full Text] [Related]  

  • 7. Periodic fluctuations in resistance of a myeloma tumor (MOPC-315-el) to cytotoxic T lymphocytes.
    Hale AH; Russell JH; d'Angeac AD; Panetti M; Hazelton B; Eisen HN
    Cell Immunol; 1981 Jul; 62(1):119-31. PubMed ID: 6973405
    [No Abstract]   [Full Text] [Related]  

  • 8. Variation in histocompatibility antigen expression on murine tumors: differences in expression and immunogenicity of H-2K region-coded unique antigens.
    Imamura M; Martin WJ
    J Immunol; 1982 Aug; 129(2):877-81. PubMed ID: 7086147
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on the nature of the cell surface antigen reacting with cytolytic T lymphocytes in murine oncornavirus-induced tumors.
    Gomard E; Levy JP; Plata F; Henin Y; Duprez V; Bismuth A; Reme T
    Eur J Immunol; 1978 Apr; 8(4):228-36. PubMed ID: 78851
    [No Abstract]   [Full Text] [Related]  

  • 10. Shifts in tumor cell phenotypes induced by signals from the microenvironment. Relevance for the immunobiology of cancer metastasis.
    Schirrmacher V
    Immunobiology; 1980 Jul; 157(2):89-98. PubMed ID: 6967852
    [No Abstract]   [Full Text] [Related]  

  • 11. Loss of reactivity of a BALB/c myeoloma tumor with allogeneic and syngeneic cytotoxic T lymphocytes.
    Russel JH; Hale AH; Inbar D; Eisen HN
    Eur J Immunol; 1978 Sep; 8(9):640-5. PubMed ID: 309400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Demonstration of a correlation between tumor cell H-2 antigen content, immunogenicity, and tumorigenicity using lectin-resistant tumor variants.
    Dennis JW; Donaghue TP; Carlow DA; Kerbel RS
    Cancer Res; 1981 Oct; 41(10):4010-9. PubMed ID: 6974593
    [No Abstract]   [Full Text] [Related]  

  • 13. The induction of cytolytic T lymphocytes with purified plasma membranes.
    Lemonnier F; Mescher TM; sherman L; Burakoff S
    J Immunol; 1978 Apr; 120(4):1114-20. PubMed ID: 76660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Some characteristics of the cyclophosphamide-induced immunopotentiating cells in the spleen of mice bearing a large MOPC-315 tumor.
    Mokyr MB; Ye QW
    Cancer Res; 1985 Oct; 45(10):4932-9. PubMed ID: 4027979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vesicular stomatitis antigens recognized by cytotoxic cells: analysis with defective interfering particles and reconstituted membrane vesicles.
    Ciavarra RP; Kang CY; Forman J
    J Immunol; 1980 Jul; 125(1):336-43. PubMed ID: 6247397
    [No Abstract]   [Full Text] [Related]  

  • 16. Lectin-induced nonlethal adhesions between cytolytic T lymphocytes and antigenically unrecognizable tumor cells and nonspecific "triggering" of cytolysis.
    Parker WL; Martz E
    J Immunol; 1980 Jan; 124(1):25-35. PubMed ID: 6765968
    [No Abstract]   [Full Text] [Related]  

  • 17. Cross-reacting antigens on L5178Y cells which serve as targets for cytotoxic T-lymphocyte lysis during establishment of the tumor dormant state.
    Weinhold KJ; Wheelock EF
    Cancer Res; 1982 Sep; 42(9):3607-16. PubMed ID: 6179603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of idiotype 315(Id315) and I-A antigens in MOPC-315 tumor cells grown in vivo.
    Reyero C; Burger DE; Ritacco S; Varga JM
    Cell Immunol; 1982 Nov; 73(2):290-8. PubMed ID: 6961954
    [No Abstract]   [Full Text] [Related]  

  • 19. Mechanisms of immune lysis. I. Physiological distinction between target cell death mediated by cytotoxic T lymphocytes and antibody plus complement.
    Russell JH; Masakowski VR; Dobos CB
    J Immunol; 1980 Mar; 124(3):1100-5. PubMed ID: 6965686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The in vitro generation of H-2-restricted cytotoxic T cells to AKR/Gross leukemia virus-induced tumors. I. Requirement for stimulation with allogeneic leukemia cells in vivo.
    Green WR
    J Immunol; 1982 Mar; 128(3):1043-9. PubMed ID: 6976986
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.